Research news
We are partnering with the British Neuroscience Association (BNA) to plan and deliver the BNA International Festival of Neuroscience 2023.
An important research partnership involving Parkinson’s UK, pharmaceutical company UCB and the Parkinson’s Foundation has published their first results in a study designed alongside people living with Parkinson’s.
Campaigners share their work and plan activities to improve Parkinson’s care
We’re calling on the Parkinson’s community to take part in 5 important clinical studies that are currently at risk of closure.
Biotech company, NRG Therapeutics, has today announced an Innovate UK award to continue its drug development project, supported by the Parkinson's Virtual Biotech, into life-changing new treatments.
Research led by Cambridge University and part funded by Parkinson’s UK shows that a form of brain scan could help identify those at risk of specific Parkinson’s symptoms.
A trial of a new miniaturised deep brain stimulation (DBS) device, being carried out at Southmead Hospital in Bristol, aims to make improvements to existing surgery.
A new partnership between Alex Echo, Hydrow and Parkinson’s UK will raise awareness of Parkinson’s and the benefits of physical activity.
As a new clinical trial begins, we explore the potential and next steps for a Parkinson’s watch that monitors symptoms.
The TOP HAT clinical trial for visual hallucinations in Parkinson's and Lewy body dementia has recently opened 4 new trial sites.